The Effect of Deep Tissue Massage on Respiratory Parameters in People With Asthma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorJagiellonian University
About this trial
Bronchial asthma, as a chronic inflammatory disease of the respiratory tract, significantly reduces the quality of life of patients. Standard treatment includes pharmacotherapy, but a holistic approach, including manual therapies, can support pharmacological therapy, reducing the need for drugs.
The aim of the research is to verify whether deep tissue massage (DTM) techniques applied to the chest significantly affect respiratory parameters in people with asthma. The study is the next stage of the study conducted on healthy people. After obtaining positive results in the study involving people not suffering from respiratory diseases, the next step is to examine people with, in this case, bronchial asthma. It is important to determine whether the use of this form of manual therapy can bring benefits in the context of improving respiratory functions, reducing respiratory muscle tension and relieving subjective symptoms associated with asthma, such as shortness of breath or limitations in everyday functioning.
The hypothesis assumes that DTM techniques can have a bigger effect on the respiratory system than classic massage (CM).
The study is a randomized controlled trial, where participants will be randomly assigned to one of two groups: the study group (subjected to DTM) or the control group (subjected to CM). Before and after the massage intervention, participants will undergo spirometry to assess the changes in respiratory parameters. The obtained data will then be analyzed for effects on respiratory parameters and differences between both groups.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
diagnosed with bronchial asthma
stable health condition, allowing participation in the study
informed consent to participate in the study
Disqualifiers
acute or chronic comorbidities that may affect the results (e.g. COPD, heart failure, cancer)
any chest surgery performed within the last 6 months
contraindications to massage (e.g. skin infections, wounds)
pregnancy
Trial design
Design model
Parallel
Treatments tested in this trial
Deep Tissue Massage
Procedure/SurgeryAdministered as a soft tissue mobilization performed by the therapist with fingertips, knuckles, elbows and/or fists on the tissues that manifest symptoms of fascial restrictions. The techniques were performed with individually adjusted force until the change (eg. increased mobility) in the tissue being treated was stated by the therapist.
Classic massage
Procedure/SurgeryThe subject was lying supine on the table, with a roller placed under the knee joints, the upper limbs along the body. The following sequence of techniques was used in the longitudinal and transverse strands and in the intercostal spaces (excluding the breast in women): effleurage, friction, petrissage, pressures, tapotement and vibrations.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Deep Tissue Massage GroupExperimental treatment 1 intervention
Group B: Classic Massage GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Assessment of change of lung vital capacity
The vital capacity of the lungs will be assessed with spirometer. The subject stood with legs hip-width apart. For each measurement, disposable cardboard mouthpieces will be used. The examined person holds the device vertically with both hands. At the examiner's command, subject will take in as much air as possible, then tightly biet the mouthpiece with his mouth, and with all of their strength, exhale air into the device for as long as possible. The subject will have only 1 attempt-measured values were recorded with an accuracy of 50 mL.
Time frame
twice: before and immediately after procedure administration in both groups2
Assessment of change of chest circumference
The chest circumference will be measured with a measuring tape, wrapped horizontally around the chest at the level of the xiphoid process. The subject stand with feet hip-width apart, arms hanging along the body. At the command, the subject will take a maximum breathe in (first measurement) and exhale to the maximum for the next (second measurement). Obtained values will be recorded with an accuracy of 0.5 cm.
Time frame
twice: before and immediately after procedure administration in both groups3
Assessment of change of blood oxygen saturation
Testing blood oxygen saturation will be performed in a sitting position with digital pulseoximeter. The device will be put on the second finger of the left hand each time. The highest value displayed by the pulseoximeter within 30 s will be recorded with an accuracy of 1%.
Time frame
twice: before and immediately after procedure administration in both groups4
Asessment of change of Peak Expiratory Flow (PEF)
Dynamic spirometry test will be performed with spirometer to assess the peak expiratory flow (PEF) measured in liters per second \[l/s\]. The subject will sit with his legs on the floor-hip joint flexed at an angle of 70o-90o and carry out the following command: "Breathe calmly. On my command, breathe in as much as possible, as quickly as possible, as intensively as possible, and while at the top of the inhalation, without waiting, breathe out as hard and as long as possible ". This cycle will be performed at least 3 times obtaining 3 measurements and the mean value will be calculated.
Time frame
twice: before and immediately after procedure administration in both groupsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: